165 related articles for article (PubMed ID: 30706585)
21. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand.
Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P
Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831
[TBL] [Abstract][Full Text] [Related]
22. Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative Surveys.
Krentel A; Damayanti R; Titaley CR; Suharno N; Bradley M; Lynam T
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005027. PubMed ID: 27812107
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of mass drug administration in the program to control imported lymphatic filariasis in Thailand.
Toothong T; Tipayamongkholgul M; Suwannapong N; Suvannadabba S
BMC Public Health; 2015 Sep; 15():975. PubMed ID: 26415693
[TBL] [Abstract][Full Text] [Related]
24. The fight against lymphatic filariasis: perceptions of community drug distributors during mass drug administration in coastal Kenya.
Kusi C; Steinmann P; Merten S
Infect Dis Poverty; 2020 Mar; 9(1):22. PubMed ID: 32114985
[TBL] [Abstract][Full Text] [Related]
25. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs.
Cantey PT; Rout J; Rao G; Williamson J; Fox LM
PLoS Negl Trop Dis; 2010 Jun; 4(6):e728. PubMed ID: 20628595
[TBL] [Abstract][Full Text] [Related]
26. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
[TBL] [Abstract][Full Text] [Related]
27. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
28. Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.
Loukouri A; Méité A; Koudou BG; Goss CW; Lew D; Weil GJ; N'Goran EK; Fischer PU
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008642. PubMed ID: 32976514
[TBL] [Abstract][Full Text] [Related]
29. Assessment of treatment impact on lymphatic filariasis in 13 districts of Benin: progress toward elimination in nine districts despite persistence of transmission in some areas.
Boko-Collins PM; Ogouyemi-Hounto A; Adjinacou-Badou EG; Gbaguidi-Saizonou L; Dossa NI; Dare A; Ibikounle M; Zoerhoff KL; Cohn DA; Batcho W
Parasit Vectors; 2019 May; 12(1):276. PubMed ID: 31146779
[TBL] [Abstract][Full Text] [Related]
30. Monitoring migrant groups as a post-validation surveillance approach to contain the potential reemergence of lymphatic filariasis in Togo.
Dorkenoo MA; Tchankoni MK; Yehadji D; Yakpa K; Tchalim M; Sossou E; Bronzan R; Ekouevi DK
Parasit Vectors; 2021 Mar; 14(1):134. PubMed ID: 33653393
[TBL] [Abstract][Full Text] [Related]
31. Impact of mass drug administration on elimination of lymphatic filariasis in Surat city, India.
Vaishnav KG; Desai HS; Srivastava PK; Joshi PT; Kurian G; Thakor HG; Dhariwal AC
J Commun Dis; 2012 Dec; 44(4):251-9. PubMed ID: 25145075
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
33. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
[TBL] [Abstract][Full Text] [Related]
34. Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis.
Andersen BJ; Rosa BA; Kupritz J; Meite A; Serge T; Hertz MI; Curtis K; King CL; Mitreva M; Fischer PU; Weil GJ
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007697. PubMed ID: 31557154
[TBL] [Abstract][Full Text] [Related]
35. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
[TBL] [Abstract][Full Text] [Related]
36. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.
Kapa DR; Mohamed AJ
Int Health; 2020 Dec; 13(Suppl 1):S17-S21. PubMed ID: 33349881
[TBL] [Abstract][Full Text] [Related]
37. Lymphatic filariasis elimination status: Wuchereria bancrofti infections in human populations and factors contributing to continued transmission after seven rounds of mass drug administration in Masasi District, Tanzania.
Lupenza ET; Gasarasi DB; Minzi OM
PLoS One; 2022; 17(1):e0262693. PubMed ID: 35045109
[TBL] [Abstract][Full Text] [Related]
38. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
Devi RR; Raju V
J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
[TBL] [Abstract][Full Text] [Related]
39. Intrarater Reliability of Tonometry and Bioimpedance Spectroscopy to Measure Tissue Compressibility and Extracellular Fluid in the Legs of Healthy Young People in Australia and Myanmar.
Douglass J; Graves P; Gordon S
Lymphat Res Biol; 2017 Mar; 15(1):57-63. PubMed ID: 27673568
[TBL] [Abstract][Full Text] [Related]
40. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.
Krentel A; Fischer PU; Weil GJ
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2447. PubMed ID: 24278486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
